Sickle-Cell Transfusions
Abstract
A trial designed to see whether children with sickle cell anemia at high risk for stroke could safely stop receiving periodic red blood cell transfusions after a minimum of 30 months was halted last month by the National Heart, Lung, and Blood Institute, in Bethesda, Md. Early results from the Stroke Prevention Trial (STOP) 2 trial indicated that stopping transfusions cannot be recommended (http://www.nhlbi.nih.gov). New findings indicate that stopping red blood cell transfusions in children...